Polygenic Embryo Screening: Where Do We Stand? – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared a post on LinkedIn:
“Polygenic Embryo Screening: Where Do We Stand?
Polygenic embryo screening (PES) can now assess IVF embryos for risks of heart disease, diabetes, schizophrenia and cancers. It’s already available, but highly controversial.
The disconnect: patients show strong interest – healthcare professionals have serious concerns.
Join this ESHRE webinar as international experts share new research on these diverging attitudes. Through focused presentations and panel discussion, we’ll explore:
- What drives patient demand vs. professional hesitation
- How views differ across cultures and demographics
- The implications for policy, education and patient care
Be part of shaping how we navigate this emerging frontier in hashtag#ReproductiveGenetics.
Date: 10 February 2026 | 17:00 CET
Find out more.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 6, 2026, 07:48Did You Know You Can Actively Contribute to ESHRE Guidelines? – ESHRE
-
Jun 6, 2026, 07:44Subfertility and Congenital Anomalies – Fertility and Sterility
-
Jun 6, 2026, 07:38France, Belgium, UK, Spain, and Quebec Compared in New ART Funding Analysis – RBMO
-
Jun 6, 2026, 07:25New ESHRE Podcast Explores Impact of Uterine Artery Occlusion on Ovarian Reserve – ESHRE
-
Jun 6, 2026, 07:22Khalil Faaed: Is the Zygote Already Revealing Its Future?
-
Jun 6, 2026, 07:16Did You Know Your Ovaries Operate in Waves? – Fertility Plus
-
Jun 6, 2026, 07:12Kazem Nouri: Women’s Health Day Highlights Fertility Preservation, Family Planning and Endometriosis
-
Jun 6, 2026, 07:10PCOS Is Now PMOS, A New Name for a Complex Condition! – Gedeon Richter France
-
Jun 6, 2026, 07:06Research Highlights Increased PAS Risk in Programmed-Cycle Frozen Embryo Transfers – RBMO